Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in <i>MET</i>-Addicted Cancer by Jooseok Kim, Kyung Eui Park, Yoo-Seong Jeong, YeongMun Kim, Hayeon Park, Ji-Hye Nam, Kyungsoo Jung, Woo Sung Son, Hun Soon Jung, Jong-Hwa Lee, Seong Hoon Jeong, Nam Ah Kim, Jae Du Ha, Sung Yun Cho, Yoon-La Choi, Suk-Jae Chung, Jun Young Choi, Sungyoul Hong, Young Kee Shin

Get full text